Topic

Aetna (CVS Health)

A collection of 1144 issues

Getting Berinert (C1-Esterase Inhibitor) Covered by Aetna CVS Health in Texas: Complete Prior Authorization Guide

Answer Box: Quick Path to Approval To get Berinert (C1-esterase inhibitor, IV) covered by Aetna CVS Health in Texas, you need prior authorization with documented HAE diagnosis, failed alternative treatments, and specialist prescription. Submit the Aetna Berinert precertification form electronically via Availity or fax to 1-866-249-6155. Include lab results showing

The Requirements Checklist to Get Bavencio (avelumab) Covered by Aetna (CVS Health) in Illinois

Answer Box: Get Bavencio (avelumab) Covered by Aetna (CVS Health) in Illinois Fastest Path to Approval: Submit prior authorization with complete pathology reports, platinum chemotherapy history, and staging documentation. For Merkel cell carcinoma, provide metastatic disease confirmation. For urothelial carcinoma, document stable disease after platinum therapy within 4-10 weeks. First

Get Pomalyst (Pomalidomide) Covered by Aetna CVS Health in California: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Pomalyst Covered by Aetna CVS Health in California Pomalyst (pomalidomide) requires prior authorization from Aetna CVS Health, REMS program enrollment, and specialty pharmacy dispensing. Success depends on documenting prior therapy failures (lenalidomide + proteasome inhibitor) and completing all REMS requirements. Fast track to approval: 1. Enroll in PS-Pomalidomide

How to Get Tavalisse (fostamatinib) Covered by Aetna CVS Health in Texas: Complete PA Guide with Appeal Scripts

Answer Box: Getting Tavalisse Covered by Aetna CVS Health in Texas Aetna CVS Health requires prior authorization for Tavalisse (fostamatinib) with strict step therapy requirements. You must document failure of corticosteroids, immunoglobulins, and at least one TPO receptor agonist. The prescription must come from a hematologist, and the drug must

Aetna (CVS Health) Coverage Criteria for Therakos CELLEX Photopheresis in New Jersey: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Therakos CELLEX Covered by Aetna (CVS Health) in New Jersey Aetna (CVS Health) covers Therakos CELLEX photopheresis for cutaneous T-cell lymphoma (CTCL) and steroid-refractory graft-versus-host disease (GVHD) when specific medical necessity criteria are met. Your fastest path to approval: 1) Have your specialist (dermatologist, hematologist, or oncologist)

Do You Qualify for Crysvita (Burosumab) Coverage by Aetna CVS Health in New York? Decision Tree & Next Steps

Quick Answer: To get Crysvita (burosumab) covered by Aetna CVS Health in New York, you need genetic confirmation of XLH or biochemical proof of TIO, documented failure of conventional therapy, and submission through CVS Specialty at 1-866-814-5506. Most approvals take 30-45 days with complete documentation. If denied, file an internal

How to Get Qalsody (tofersen) Covered by Aetna (CVS Health) in California: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Qalsody (tofersen) Approved by Aetna (CVS Health) in California Aetna (CVS Health) requires prior authorization for Qalsody (tofersen) with documented SOD1 mutation, neurologist prescription, and baseline assessments. First step: Submit Aetna's Qalsody precertification form with genetic test results, ALSFRS-R scores, and clinical notes. Standard approval

Renewing Isturisa (Osilodrostat) Approval with Aetna (CVS Health) in Michigan: Complete Timeline and Documentation Guide

Quick Answer: Renewing Isturisa (Osilodrostat) with Aetna (CVS Health) in Michigan Start your renewal 60-90 days before expiration. Submit updated clinical documentation including recent 24-hour urine free cortisol levels, morning serum cortisol, and physician notes demonstrating continued medical necessity. Use Michigan's standard prior authorization form and expect a

How to Get Oxervate (Cenegermin) Covered by Aetna CVS Health in Pennsylvania: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Oxervate (Cenegermin) Covered by Aetna CVS Health in Pennsylvania Aetna CVS Health requires prior authorization for Oxervate (cenegermin) in Pennsylvania with strict step therapy requirements. To get approved: 1) Confirm stage 2 or 3 neurotrophic keratitis diagnosis with an ophthalmologist, 2) Document failed trials of at least

How to Get Poteligeo (mogamulizumab-kpkc) Covered by Aetna CVS Health in Texas: Complete Guide to Prior Authorization, Appeals, and Cost Reduction

Answer Box: Getting Started Aetna CVS Health requires prior authorization for Poteligeo (mogamulizumab-kpkc) in Texas. You'll need documented mycosis fungoides or Sézary syndrome diagnosis, proof of at least one failed prior systemic therapy, and an oncologist's prescription. Submit through the Aetna provider portal or call 1-866-814-5506